Exome sequencing data used in the manuscript are available at <https://zenodo.org/> \[DOI: [10.5281/zenodo.3876533](https://doi.org/10.5281/zenodo.3876533)\]. All other relevant data are within the article and its Supporting Information files.

Introduction {#sec001}
============

The majority of life forms on earth exhibit approximately 24-h (circadian) behavioral and physiological rhythms generated by endogenous timekeeping mechanisms---circadian clocks. In addition to driving such endogenous rhythms, circadian clocks facilitate synchronization of organisms' rhythms to daily and seasonal changes in the environment to enhance their survivability, thereby functioning as an adaptive mechanism \[[@pbio.3000792.ref001]\]. The fundamental basis of circadian rhythm generation across all life forms are cell-autonomous molecular oscillators comprising evolutionarily conserved autoregulatory transcription-translation feedback loops \[[@pbio.3000792.ref002]\]. In higher organisms, such cell-autonomous clocks often function as a network of coupled oscillators that, in unison, drive circadian rhythms \[[@pbio.3000792.ref003]\]. Welsh and coworkers first reported that neurons within the suprachiasmatic nucleus (SCN; the master pacemaker in the hypothalamus of mammals) are surprisingly heterogeneous in their intrinsic periods of circadian firing pattern \[[@pbio.3000792.ref004]\]. Subsequent studies revealed that such period heterogeneity is not restricted to the SCN but is also observed in mammalian peripheral clock cells \[[@pbio.3000792.ref005],[@pbio.3000792.ref006]\] as well as in *Drosophila* clock cells \[[@pbio.3000792.ref007]\] and plants \[[@pbio.3000792.ref008],[@pbio.3000792.ref009]\]. The ubiquity of this phenomenon suggests that heterogeneity may be functionally relevant for circadian clocks \[[@pbio.3000792.ref010]--[@pbio.3000792.ref018]\], thus likely being a substrate for natural selection. Interestingly, the observed period heterogeneity among circadian clock cells within an organism cannot be entirely attributed to functionally different cell types, as cells of the same subtype (clonal cells) also exhibit such variation \[[@pbio.3000792.ref005],[@pbio.3000792.ref006]\]. Clonal heterogeneity or clonal phenotypic variability is common in biology and can stem from various factors such as stochastic changes in the microenvironment, stochastic partitioning of cellular components during cell division, or stochasticity in gene expression \[[@pbio.3000792.ref019]--[@pbio.3000792.ref025]\]. In this study, we aimed to explore the possible mechanisms underlying clonal heterogeneity of circadian period in human circadian oscillator cells.

Based on previous reports exploring heterogeneity in other cellular phenotypes, we hypothesized that clonal period heterogeneity in mammalian cells is due to (1) stochastic variation \[[@pbio.3000792.ref024],[@pbio.3000792.ref026]--[@pbio.3000792.ref028]\] and/or (2) heritable variation \[[@pbio.3000792.ref029]--[@pbio.3000792.ref031]\]. Since the term "stochastic" is used in the context of both nonheritable (external noise and gene expression noise) and heritable gene expression variation (epigenetic stochasticity), for the rest of this manuscript we define "stochasticity" as any nonheritable variation. To test the two above outlined hypotheses, we employed a laboratory selection approach and derived a panel of 25 clonal cell lines (from a common founding culture) exhibiting a range of periods between 22 and 28 h. We observed that the period heterogeneity among progeny clones stemming from a single parent cell is governed by both stochastic and heritable components. Moreover, the extent to which heritable and stochastic components influence circadian period varies between short- and long-period clones. We then measured expression of 20 clock and clock-associated genes in our panel and observed that variation in gene expression of at least three clock genes (transcription factors) might underlie clonal period heterogeneity. Furthermore, we report that the short- and long-period clones are differentially affected by treatment with epigenetic modifier drug and also have different methylation signatures, thus providing preliminary evidence suggesting that epigenetic variation in gene expression regulation might contribute to the heritable basis of clonal period heterogeneity.

Results {#sec002}
=======

Both heritable and stochastic components contribute to clonal period heterogeneity {#sec003}
----------------------------------------------------------------------------------

Is the variation in period among individual circadian oscillator cells due to nonheritable stochastic noise? Or is there a heritable component? To test this, we single-cell cloned a "founding culture" of human U-2 OS cells (an established model of peripheral circadian clocks) harboring a *BMAL1*-luciferase reporter construct \[[@pbio.3000792.ref032]\]. Upon reaching confluence, the period of bioluminescence rhythms from these progeny cultures was determined by live-cell bioluminescence recording. We observed a distribution of circadian periods among clones from the founding culture (23.5--27.5 h; [Fig 1A](#pbio.3000792.g001){ref-type="fig"} top panel). We further repeated this protocol for several "assay generations" by each time selecting short- and long-period clones as "parents" for the successive assay generation (study outline in [S1 Fig](#pbio.3000792.s001){ref-type="supplementary-material"}).

![Both heritable and nonheritable stochastic components contribute to clonal circadian period heterogeneity.\
**(A)** Divergence of circadian period distributions of short-period (red) and long-period (blue) clones from a common founding culture (gray) across multiple assay generations. Dashed black lines depict the mean of respective period distributions. The gray dashed lines extended from assay generation 1 depict mean period of the founding culture (assay generation 0) for visual assessment of the period divergence. Red arrows (short-period clone) and blue arrows (long-period clone) indicate the periods of representative clones selected for the successive assay generation. **(B)** Detrended bioluminescence traces of representative clones from founding culture (dashed line), SCL (red), and LCL (blue). Detrending results in truncation of 12-h data at the beginning and end of time series. **(C)** Mean circadian periods of three representative SCLs (SCL1--3) and LCLs (LCL1--3) across four assay generations. Error bars are SD (*n* = 3 experiments). Letters a--c depict statistical significance for both interassay and intra-assay generation comparisons. Same letters indicate lack of statistical significance between the average periods of SCLs and LCLs, whereas different letters indicate statistically significant differences in period (ANOVA followed by Tukey's HSD; *p* \< 0.001). Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. ANOVA, analysis of variance; HSD, honestly significant difference; LCL, long-period clonal line; rel., relative; SCL, short-period clonal line.](pbio.3000792.g001){#pbio.3000792.g001}

Interestingly, by repeating this protocol for several assay generations, we observed a directional divergence of the progenies' period distributions on either side of the founding culture's distribution ([Fig 1A and 1B](#pbio.3000792.g001){ref-type="fig"}, [S2A Fig](#pbio.3000792.s002){ref-type="supplementary-material"}). Over the course of the selection protocol, the circadian periods of short- and long-period clonal lines (SCLs and LCLs) diverged from each other and from the founding culture ([Fig 1A--1C](#pbio.3000792.g001){ref-type="fig"}). The circadian periods of both SCLs and LCLs diverged significantly by assay generation 2 ([Fig 1C](#pbio.3000792.g001){ref-type="fig"}; analysis of variance \[ANOVA\] followed by Tukey's honestly significant difference \[HSD\], *p* \< 0.001). Even though the periods of SCLs and LCLs continued to diverge through assay generations 3 and 4, the difference in periods between assay generations 2 and 4 was not statistically significant for either clones ([Fig 1C](#pbio.3000792.g001){ref-type="fig"}; ANOVA followed by Tukey's HSD, *p* = 0.52), suggesting that period divergence reached saturation. Thus, the divergence in circadian periods among clonal lines in response to the imposed directional selection suggests that heritable components underlie circadian period heterogeneity.

The mean circadian periods of progeny cultures in every assay generation were similar to their parental cultures, suggesting that the parental circadian period is a very good predictor of the mean progeny period and thus is heritable ([S2B Fig](#pbio.3000792.s002){ref-type="supplementary-material"}). However, progeny cultures continued to exhibit distribution of periods even after three assay generations when divergence of periods had reached saturation ([Fig 1A and 1C](#pbio.3000792.g001){ref-type="fig"}). Both heritable genetic variation (*V*~*H*~) and nonheritable stochastic/environmental variation (*V*~*NH*~) are known to contribute to phenotypic variation (*V*~*P*~ = *V*~*H*~ + *V*~*NH*~) observed in populations \[[@pbio.3000792.ref033],[@pbio.3000792.ref034]\]. Heritability estimates help to summarize what proportion of phenotypic variation across individuals derives from variation in heritable components as opposed to variation in nonheritable components and can be calculated as *H*^*2*^ = *V*~*H*~/*V*~*P*~, the ratio of heritable genetic variance to the total phenotypic variance, where *H*^*2*^ is termed broad-sense heritability \[[@pbio.3000792.ref033],[@pbio.3000792.ref034]\]. To explore the contributions of heritable and nonheritable components to circadian period heterogeneity, we used variance partitioning by ANOVA to estimate heritable variation (*V*~*H*~) and nonheritable variation (*V*~*NH*~) for SCLs and LCLs as described by Lynch and Walsh \[[@pbio.3000792.ref034]\] (see [S2C Fig](#pbio.3000792.s002){ref-type="supplementary-material"} and Methods for more details). In brief, we considered a group of parental SCL and LCL clones and analyzed their respective progeny clones' periods by ANOVA to obtain "between-clone" and "within-clone" variances. Between-clone variance is a measure of variation between progeny clones from different parents and represents variation due to both heritable and nonheritable components. Within-clone variance is a measure of variation within progeny clones of the same parent, and since they are genetically identical, the observed within-clone variation is likely to be primarily due to nonheritable variation ([S2C Fig](#pbio.3000792.s002){ref-type="supplementary-material"}; \[[@pbio.3000792.ref034]\]). Thus, the within-clone and between-clone variances can be used to estimate *V*~*H*~ and *V*~*NH*~ ([S2C Fig](#pbio.3000792.s002){ref-type="supplementary-material"}). We analyzed up to 73 progenies from SCLs and LCLs and found that for SCLs at assay generation 0, the *V*~*H*~ and *V*~*NH*~ were 0.65 and 0.44, respectively, suggesting that short circadian period has a stronger heritable component compared to nonheritable component and consequently is largely heritable (*H*^*2*^ = 0.6). Interestingly, even at assay generation 0, LCLs had a considerably lower *V*~*H*~ of 0.17 and a relatively higher *V*~*NH*~ (0.32) with *H*^*2*^ being 0.34, suggesting that long circadian periods have a weaker heritable component and likely are more strongly driven by nonheritable stochastic noise. By assay generation 3, *V*~*H*~ of both SCLs and LCLs drastically reduced to 0.08 and 0.09, respectively, and consequently had low heritability (0.15 for SCLs and 0.14 for LCLs), which explains the saturation of divergence in circadian periods over generations ([Fig 1C](#pbio.3000792.g001){ref-type="fig"}). However, both SCLs and LCLs continued to have higher *V*~*NH*~ (0.42 and 0.59, respectively), suggesting that the observed period heterogeneity even after three assay generations is largely due to nonheritable components ([Fig 1A](#pbio.3000792.g001){ref-type="fig"}).

To briefly assess whether the period differences between the SCLs and LCLs also translate to a different phase of entrainment in the presence of a zeitgeber cycle \[[@pbio.3000792.ref035]\], we measured bioluminescence rhythms of a representative SCL and LCL clones under two different temperature cycles. We observed that indeed the SCL exhibits an advanced phase of entrainment compared to LCL by about 3.2 ± 1.3 h (mean ± SD) under T24 (12 hours of 37°C and 33°C each; [S3 Fig](#pbio.3000792.s003){ref-type="supplementary-material"} top panel). This phase-difference further increases to about 5.8 ± 1.7 h (mean ± SD) under T26 (13 hours of 37°C and 33°C each; [S3 Fig](#pbio.3000792.s003){ref-type="supplementary-material"} bottom panel) cycles, consistent with theoretical predictions \[[@pbio.3000792.ref036]\].

Taken together, these results indicate that (1) both heritable and stochastic components contribute to clonal period heterogeneity and (2) short circadian periods have a stronger heritable component compared to long periods, which are more strongly noise driven. In addition, results from entrainment to temperature cycles reveal that circadian entrainment properties are conserved even in single-cell clones, thereby underscoring laboratory selection approach as a useful strategy to generate clonal cell populations with divergent circadian clock traits that can aid chronobiology studies, which are sometimes limited by the potential pleiotropic effects encountered using clock mutants.

Precision of circadian rhythm decreases with increasing period {#sec004}
--------------------------------------------------------------

Several earlier studies reported correlation of circadian period with rhythm precision (a measure of intercycle period stability). They suggested that precision of circadian rhythms is high when the circadian period is closer to 24 h and decreases as period deviates from 24 h, but mostly at the organismal level and within the pacemaker SCN neurons \[[@pbio.3000792.ref037]--[@pbio.3000792.ref042]\]. In addition, we find that long circadian periods are largely noise driven as compared to short periods. Thus, we tested (1) whether correlation of period with rhythm stability is also observed in peripheral oscillator cells and (2) whether the largely noise driven long-period cells exhibit stable circadian rhythms. To this end, we measured the SD of intercycle (peak-to-peak) period in our clonal lines.

We observed a significant positive correlation of intercycle period variation with the clone period (Spearman *r* = 0.51, *p* \< 0.0001; [Fig 2A](#pbio.3000792.g002){ref-type="fig"}). Clones with shorter circadian periods had a higher rhythm stability (lower SD of intercycle period), which reduces as period lengthens ([Fig 2A](#pbio.3000792.g002){ref-type="fig"}). Interestingly, not all long-period clones exhibit reduced rhythm stability, and the interclonal variation in rhythm stability appeared to be higher among long-period clones compared to their short-period counterparts ([Fig 2A](#pbio.3000792.g002){ref-type="fig"}).

![Rhythm stability is associated with period, and clonal period heterogeneity does not stem from polymorphisms.\
**(A**) Correlation of SD of intercycle (peak-to-peak) period with clonal circadian period indicating a reduction in rhythm stability with increasing clock period. **(B)** Venn diagrams depicting overlap of SNPs and CNVs identified among SCLs and LCLs with the 243 period modifier genes reported by Zhang and colleagues \[[@pbio.3000792.ref046]\]. For SNPs, numbers within brackets indicate the total number of SNPs identified, and numbers otherwise represent the total number of genes harboring the identified SNPs. **(C)** Correlation of rhythm parameters---average bioluminescence ("biolum."; green), relative amplitude ("rel. amp."; blue), and damping rate (red)---with clonal circadian period. **(D)** Regression of average bioluminescence ("avg. biolum.") of parental clones over progeny clones, indicating that parental average bioluminescence is a very good predictor of progeny bioluminescence. Green solid line is the linear regression fit with its 95% CI (green dotted line). Underlying data for (A), (C), and (D) can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. Data used for (B) are available at <https://zenodo.org/> (DOI: [10.5281/zenodo.3876533](https://doi.org/10.5281/zenodo.3876533)). CNV, copy number variant; cps, counts per second; LCL, long-period clonal line; SCL, short-period clonal line; SNP, single nucleotide polymorphism.](pbio.3000792.g002){#pbio.3000792.g002}

These results suggest that rhythm stability is indeed associated with clock period even in peripheral cellular oscillators, with long-period oscillators having a higher propensity to exhibit reduced rhythm stability. However, the nature of association between rhythm stability and clock period does not agree with previous reports, as will be discussed later.

Clonal period heterogeneity is ubiquitous and likely not caused by genetic polymorphisms {#sec005}
----------------------------------------------------------------------------------------

The U-2 OS cells used in our study are osteosarcoma-derived cells, and cancer-derived cell lines are known to have a higher mutation propensity \[[@pbio.3000792.ref043],[@pbio.3000792.ref044]\]. Therefore, we asked whether the observed circadian period heterogeneity is specific to U-2 OS cells (and possibly other hypermutable cells) due to genetic instability or whether it is ubiquitous and can be extrapolated to cell types in other species. To test this, we imposed a similar artificial selection protocol for one assay generation on mouse cells NIH 3T3 (an immortalized murine fibroblast cell line with a much lower spontaneous mutation propensity \[[@pbio.3000792.ref045]\]) expressing a *BMAL1* promoter--driven luciferase. Similar to U-2 OS cells, single-cell cloning of NIH 3T3 cells from founding culture resulted in a distribution of periods 22.80 ± 0.7 h (mean ± SD) at assay generation 0 ([S4 Fig](#pbio.3000792.s004){ref-type="supplementary-material"}). We then selected short- and long-period clones from this distribution and single-cell cloned these for the next assay generation. As in U-2 OS cells, we observed that by assay generation 1, the average period of short clones reduced by 1.2 h to 21.74 ± 0.2 h (mean ± SD), whereas that for long-period clones increased by 0.5 h to 23.4 ± 1.1 h (mean ± SD; [S4 Fig](#pbio.3000792.s004){ref-type="supplementary-material"}). These results suggest that clonal period heterogeneity is likely not due to hypermutation in cancer cells but appears to be a ubiquitous phenomenon.

To nevertheless test whether period divergence over assay generations might be caused by differential accumulation of period-changing mutations in SCLs versus LCLs, we sequenced the exomes of three representative SCLs and LCLs each along with the founding culture. When referenced against the human genome, we found an average of 168,982 ± 7,493 (SD) single nucleotide polymorphisms (SNPs) across the seven sequenced clones, thus underscoring the hypermutable genome of U-2 OS cells. However, when we compared SNPs in SCLs and LCLs with those in the founding culture, we observed that about 99.8% of all SNPs in SCLs and LCLs were already present in the founding culture. We then compared SNPs shared between all three SCLs and LCLs and identified 311 SNPs across 274 genes in SCLs and 222 SNPs across 189 genes in LCLs ([S1 Table](#pbio.3000792.s013){ref-type="supplementary-material"}). These SCL- and LCL-specific SNPs are polymorphisms that likely arose in our clones during the course of the selection and may, in principle, underlie the observed period differences. Zhang and colleagues \[[@pbio.3000792.ref046]\] executed a genome-wide RNAi screen using U-2 OS cells and reported 243 genes, which upon knockdown resulted in circadian period changes ([S1 Table](#pbio.3000792.s013){ref-type="supplementary-material"}). To test whether the SCL- and LCL-specific SNPs that we identified may have a causal link with circadian period, we compared the list of period modifier genes reported by Zhang and colleagues \[[@pbio.3000792.ref046]\] with the genes harboring the identified SNPs in our clones. We found that SCLs had four common SNPs in four period modifier genes (*ZNF91*, *SART3*, *GFAP*, *ZMAT3*) and one common SNP in *CLOCK*, whereas none of the common genes harboring LCL-specific SNPs were found to be period modifiers ([Fig 2B](#pbio.3000792.g002){ref-type="fig"}). Annotation of the five identified SNPs in SCLs revealed that none of the SNPs caused an amino acid change in the corresponding proteins. One SNP (in *ZNF91*) was a synonymous variant, three SNPs (in *SART3*, *CLOCK*, and *ZMAT3)* were intronic variants, and one SNP (in *GFAP*) was a 3′-UTR variant ([S2 Table](#pbio.3000792.s014){ref-type="supplementary-material"}). In addition, none of these SNPs were present in annotated splice junctions, promoters, enhancer elements, or any experimentally verified transcription factor, RNA binding protein, or microRNA binding sites, thus suggesting that these SNPs are unlikely to be causally linked to short period in SCLs ([S2 Table](#pbio.3000792.s014){ref-type="supplementary-material"}). To further test this, we compared the expression levels of these between three representative SCLs and LCLs and did not find any significant differences in their expression levels ([S5 Fig](#pbio.3000792.s005){ref-type="supplementary-material"}; expression of *CLOCK* will be discussed below). These data also indicate that genetic polymorphisms acquired during the selection process are unlikely to contribute to the short or long circadian periods in our clones. In addition, we analyzed copy number variants (CNVs) and did not find any CNV commonly shared by all three SCLs or LCLs. When CNVs across all three clones were pooled together, we found 23 CNVs across the three SCLs and 51 CNVs across the three LCLs with at least one copy gain or loss ([S3 Table](#pbio.3000792.s015){ref-type="supplementary-material"}). However, none of these genes were reported by Zhang and colleagues \[[@pbio.3000792.ref046]\] as period modifier genes either ([Fig 2B](#pbio.3000792.g002){ref-type="fig"}; [S3 Table](#pbio.3000792.s015){ref-type="supplementary-material"}). Interestingly, among the six clones analyzed, four clones (two SCLs and two LCLs) had a copy number loss in *CLOCK* ([S3 Table](#pbio.3000792.s015){ref-type="supplementary-material"}), but since they were commonly shared between the two period clones, we conclude copy number loss in *CLOCK* is unlikely to be causally linked to period differences between SCLs and LCLs.

Altogether, these results further indicate that clonal period heterogeneity is a ubiquitous phenomenon and is unlikely to be due to genetic polymorphisms.

Differential expression of E-Box-associated factors may underlie clonal period heterogeneity {#sec006}
--------------------------------------------------------------------------------------------

Having established that the heritable components underlying period differences observed between SCLs and LCLs are likely not due to accumulated polymorphisms, we further aimed to explore the heritable basis of period heterogeneity. During the course of our experiments, we observed that SCLs and LCLs consistently exhibited differences in average bioluminescence (average bioluminescence counts across a circadian cycle). LCLs had higher average bioluminescence compared to SCLs ([S2A Fig](#pbio.3000792.s002){ref-type="supplementary-material"}). This encouraged us to test correlation of circadian period with other parameters, and we observed a strong significant positive correlation of average bioluminescence with period (Spearman *r* = 0.65, *p* \< 0.0001), but not to relative amplitude (Spearman *r* = −0.32, *p* \< 0.0001) and damping rate (Spearman *r* = 0.28, *p* \< 0.0001), which only weakly correlated with period ([Fig 2C](#pbio.3000792.g002){ref-type="fig"}). Furthermore, average bioluminescence of parental clones was found to the best predictor of the respective progeny values (*R*^2^ = 0.76; [Fig 2D](#pbio.3000792.g002){ref-type="fig"}), whereas relative amplitude (*R*^2^ = 0.04; [S6A Fig](#pbio.3000792.s006){ref-type="supplementary-material"}) and damping rate (*R*^2^ = 0.40; [S6B Fig](#pbio.3000792.s006){ref-type="supplementary-material"}) were only poor predictors.

Based on the above-described results, we reasoned that average bioluminescence can, in principle, serve as a proxy for the average expression of the underlying gene (*BMAL1*) and thus hypothesized that variation in average gene expression of circadian clock genes might underlie clonal period heterogeneity. To test this prediction, we used the NanoString multiplex platform to measure the average expression levels of 20 clock and clock-associated genes ([S4 Table](#pbio.3000792.s016){ref-type="supplementary-material"}) across our panel of 25 clones exhibiting periods spanning 22--28 h. To do so, we carefully plated cells to avoid any inadvertent synchronization due to handling, let the cells grow for 6 days without any medium change, and isolated RNA at 144.5 h post plating. We observed that when handled this way, the cell population was essentially arrhythmic by day 6, with relative amplitudes reducing by approximately 95% compared with day 1 amplitude (see [Methods](#sec009){ref-type="sec"}; [S7A--S7C Fig](#pbio.3000792.s007){ref-type="supplementary-material"}; [S1 Text](#pbio.3000792.s019){ref-type="supplementary-material"}).

When then analyzing the expression levels of the 20 clock and clock-associated genes ([S4 Table](#pbio.3000792.s016){ref-type="supplementary-material"}) at 144.5 h post plating across our panel of 25 clones, not surprisingly, we observed a high cross-correlation in expression of the measured genes ([S8A Fig](#pbio.3000792.s008){ref-type="supplementary-material"}). This is likely due to the high interconnectivity in the circadian clock molecular loop, wherein expression changes in one gene may drive expression changes in multiple other genes. We therefore subjected the dataset to principal component analysis (PCA), which is a useful technique for analyzing such high-dimensional correlated data. PCA facilitates reduction of data dimensionality by transforming a number of correlated variables (genes in this case) into uncorrelated principal components (PCs), which are linear combinations of the variables (genes) each having a different contribution to the PC. By identifying relevant PCs, one can further look at what variables (genes) have the most influence on the PC, thus helping identify genes contributing the most to the observed heterogeneity in periods. Based on the Broken Stick model (see [Methods](#sec009){ref-type="sec"} and \[[@pbio.3000792.ref047]\]), we retained the first two PCs, which collectively explained 70.2% of the variance in period ([Fig 3A](#pbio.3000792.g003){ref-type="fig"}). Interestingly, the first two PCs also clustered the panel of clones into three categories of short- (22.3--23 h), intermediate- (23.8--26.9 h), and long-period (27.6--28.2 h) clones ([Fig 3B](#pbio.3000792.g003){ref-type="fig"}). PC1 clustered the clones into two groups: (1) intermediate periods and (2) the rest including both short- and long-period clones (nonintermediate). In contrast, PC2 appeared to be important for the three observed clusters ([Fig 3B](#pbio.3000792.g003){ref-type="fig"}). Since any given PC is a linear combination of all genes with different coefficients (a measure of magnitude of a gene's influence on a PC), we use the cos^2^ values ([Fig 3C](#pbio.3000792.g003){ref-type="fig"}) and contributions of genes to PC2 ([S8B--S8D Fig](#pbio.3000792.s008){ref-type="supplementary-material"}), both of which are measures to assess which genes have the most influence on a PC. We shortlisted the top 25% of the candidate genes (*ARNTL2*, *BHLHE40*, *DBP*, *NR1D2*, *PER2*) that we hypothesized to largely account for the period heterogeneity in our panel of clones.

![Inheritance of clock-gene expression patterns might govern clonal period heterogeneity.\
**(A)** Scree plot depicting the percentage of variance explained by the 19 PCs (black bars) and the expected values based on the Broken Stick model (red line). **(B)** Factor map of individual clones plotted across PCs 1 and 2 reveals that the first two PCs cluster the clones in three clusters of short- (red), intermediate- (black), and long-period (blue) clones. **(C)** Cos^2^ values (a measure of the extent of influence of a gene on the PC) of the 19 genes for PCs 1--5. The color and size of circles represent the magnitude of cos^2^ value. **(D)** Hierarchical clustering based on the expression of five genes selected from PC2. With the exception of one clone, all others clustered into three groups of short, intermediate, and long clones (red, black, and blue dashed rectangles, respectively). **(E)** Hierarchical clustering based on the expression of five genes from PC1 resulted in two clusters: (1) intermediate period (black dashed rectangle) and (2) short and long period (green dashed rectangle). Color coding of clones in (D) and (E) is the same as in (B). Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. PC, principal component.](pbio.3000792.g003){#pbio.3000792.g003}

Hierarchical clustering based on expression of the five shortlisted candidate genes clustered clones based on periods similar (with one exception) to that by the first two PCs ([Fig 3B](#pbio.3000792.g003){ref-type="fig"}). The amalgamation schedule suggested a possibility of three clusters (red, blue, and black dashed rectangles, [Fig 3D](#pbio.3000792.g003){ref-type="fig"}), which was also in agreement with the optimal cluster number reported by five different indexes ([S9A--S9E Fig](#pbio.3000792.s009){ref-type="supplementary-material"}). Clustering-based heat map revealed that the expression of *ARNTL2* and *BHLHE40* correlated positively with the circadian period, and *DBP* and *NR1D2* correlated negatively ([Fig 3D](#pbio.3000792.g003){ref-type="fig"}, [S10A Fig](#pbio.3000792.s010){ref-type="supplementary-material"}). We also similarly shortlisted top 25% genes from PC1 (*NR1D1*, *CLOCK*, *CSNK1D*, *CIPC*, and *NFIL3*), and as expected, we observed that these genes were not sufficient to discriminate the short and long periods and resulted in just two clusters---intermediate and nonintermediate ([Fig 3E](#pbio.3000792.g003){ref-type="fig"}, [S9F--S9J Fig](#pbio.3000792.s009){ref-type="supplementary-material"}). Interestingly, all five genes from PC1 have higher expression in "intermediate-period" clones, and their expression reduces as the period deviates from "intermediate" ([Fig 3E](#pbio.3000792.g003){ref-type="fig"}, [S10B Fig](#pbio.3000792.s010){ref-type="supplementary-material"}). We compared these genes with the CNVs identified earlier and did not find any of the clones that harbored a CNV for the above assayed genes (except *CLOCK*), thereby ruling out the possibility that the observed gene expression differences is due to polymorphisms. As mentioned earlier, both SCLs and LCLs had copy number loss for *CLOCK*, and this explains the reduced gene expression in both sets of clones ([Fig 3E](#pbio.3000792.g003){ref-type="fig"}). Furthermore, reduced expression of *CLOCK* in both SCLs and LCLs suggests that the intronic SNP identified in SCLs is unlikely to be causally linked to period differences between the clones. Thus, we hypothesized that changes in expression of PC2 genes are likely to underlie circadian period heterogeneity in our clones.

If differences in expression of the shortlisted PC2 genes govern period heterogeneity, then depletion of these genes should result in large period change, whereas depletion of those from PC1 should not have a significant effect on period. Specifically, based on their expression patterns ([Fig 3D](#pbio.3000792.g003){ref-type="fig"}), knockdown of *ARNTL2* and *BHLHE40* should shorten the circadian period, whereas *DBP* and *NR1D2* knockdown should result in period lengthening. To test this, we used RNAi-mediated knockdown of the shortlisted genes in three short-, two intermediate-, and three long-period clones (based on clustering in [Fig 3D](#pbio.3000792.g003){ref-type="fig"}) and studied the effect on circadian period. Indeed, we observed that knockdown of *NR1D2* resulted in significant period lengthening across all clones, whereas *BHLHE40* and *ARNTL2* knockdown resulted in significant period shortening (mixed-model ANOVA followed by Tukey's HSD; *p* \< 0.00001; [Fig 4A and 4B](#pbio.3000792.g004){ref-type="fig"}). *NR1D2* knockdown had the largest effect on period, significantly higher compared to all other genes across both the PCs, followed by *BHLHE40*, which was similar to *ARNTL2* and had a significantly higher effect on period compared to all other genes. Knockdown of none of the other genes across both PCs resulted in a period change significantly differing either from zero (one-sample *t* test, *p* \> 0.05) or from each other (mixed-model ANOVA followed by Tukey's HSD; *p* \> 0.05; [Fig 4A and 4B](#pbio.3000792.g004){ref-type="fig"}). Accordingly, we observed that the average absolute period change upon knockdown of PC2 genes was significantly higher than that by PC1 genes ([Fig 4C](#pbio.3000792.g004){ref-type="fig"}).

![Epigenetically regulated expression of E-Box-associated factors may govern clonal period heterogeneity.\
Period change (compared to nonsilencing scrambled shRNA control) upon knockdown of the **(A)** five PC2 genes and **(B)** three PC1 genes for the short- (red), intermediate- (gray), and long-period (blue) clones. Bars with different letters indicate significant differences (*p* \< 0.05), and bars with the same letter are not significantly different from each other (mixed-model ANOVA followed by Tukey's HSD). Numbers within square brackets indicate the knockdown efficiency of the respective gene. **(C)** Averaged absolute ("abs.") period change across all clones upon knockdown of genes from PC2 and PC1. **(D)** Period change (compared to vehicle control) upon treatment of short- (red), intermediate- (gray), and long-period (blue) clones with HDAC inhibitor SAHA (1.6 μM). **(E)** Methylation percentage of CpG islands proximal to the transcription start site of the three genes---ARNTL2, NR1D2, and BHLHe49. For all panels in this figure, *n* = 3--4 experiments and error bars are SD (\**p* \< 0.05; \*\**p* \< 0.001; \*\*\*\**p* \< 0.0001). Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. ANOVA, analysis of variance; HDAC, histone deacetylase; HSD, honestly significant difference; LCL, long-period clonal line; PC, principal component; SAHA, suberoylanilide hydroxamic acid; SCL, short-period clonal line; shRNA, short hairpin RNA.](pbio.3000792.g004){#pbio.3000792.g004}

Taken together, these results suggest that differential expression of *NR1D2*, *BHLHE40*, and *ARNTL2* likely underlies clonal heterogeneity in circadian period.

Epigenetic regulation might underlie altered gene expression patterns associated with clonal period heterogeneity {#sec007}
-----------------------------------------------------------------------------------------------------------------

Having observed that clonal period heterogeneity is associated with altered gene expression patterns, we next asked, What drives such altered expression among clonal cells? We dismissed the possibility of genetic polymorphism as being unlikely (see above and Discussion) and hypothesized that epigenetic variation might account for the observed differences in gene expression patterns among clonal lines.

To this end, we treated all 25 clonal cell populations in our panel with the commonly used epigenetic modifier suberoylanilide hydroxamic acid (SAHA) and studied the effect of the treatment on clone period. SAHA is a class I and class II histone deacetylase (HDAC) inhibitor that up-regulates gene expression by multiple mechanisms \[[@pbio.3000792.ref048]\]. We reasoned that if reduction in expression of the identified subset of genes across our clonal panel is due to epigenetic suppression (in this case, acetylation status), treatment with SAHA should up-regulate the expression of these genes, thereby lengthening and shortening the circadian period in short- and/or long-period clones, respectively.

Interestingly, we observed that treatment with SAHA differentially influenced the short-, intermediate-, and long-period clones. SAHA treatment resulted in a significant period shortening in the long-period clones (ANOVA followed by Tukey's HSD, *p* \< 0.05; [Fig 4D](#pbio.3000792.g004){ref-type="fig"}), whereas the magnitude of period change in short- and intermediate-period clones did not differ from each other (ANOVA followed by Tukey's HSD, *p* = 0.85) or from zero (one-sample *t* test, *p* \> 0.05; [Fig 4D](#pbio.3000792.g004){ref-type="fig"}).

In addition, since the three PC2 genes (*NR1D2*, *BHLHE40*, and *ARNTL2*) whose expression strongly correlated with circadian period in our clones and upon knockdown had significant impact on period, we asked whether methylation may regulate the observed differential expression of one or more of these genes among our clones. To study this, we used three short- and three long-period clones and assessed the methylation status of CpG islands proximal to transcription start sites of these genes. In accordance with reduced *BHLHE40* expression in the short-period clones ([Fig 3D](#pbio.3000792.g003){ref-type="fig"}), we observed that the CpG island upstream of *BHLHE40* was significantly more methylated in the short-period clones compared to that in long-period clones (*t* test, *p* \< 0.01; [Fig 4E](#pbio.3000792.g004){ref-type="fig"}), whereas the clones did not differ in their methylation of CpG islands upstream of *ARNTL2* and *NR1D2* genes ([Fig 4E](#pbio.3000792.g004){ref-type="fig"}).

The possible reasons for the differential effects of SAHA treatment on short- and long-period clones will be discussed later, but taken together, these results provide preliminary evidence suggesting that differential epigenetic regulation of circadian clock--gene expression might underlie clonal period heterogeneity.

Discussion {#sec008}
==========

We used human U-2 OS cells to investigate whether period heterogeneity in circadian clock network stems from stochastic (nonheritable) components or whether it has a heritable component. We employed a laboratory selection protocol to select for clonal cell lines exhibiting short and long circadian periods (from a common founding culture) through which we derived a panel of 25 clonal cell populations exhibiting circadian periods between 22 and 28 h.

We observed that, in response to imposed selection, circadian periods of SCLs and LCLs continued to diverge from that of the founding culture and saturated over four assay generations ([Fig 1A--1C](#pbio.3000792.g001){ref-type="fig"}; [S2B Fig](#pbio.3000792.s002){ref-type="supplementary-material"}), suggesting that period heterogeneity in clonal populations is not entirely stochastically driven, but has a considerable heritable component. Interestingly, despite the saturation in period divergence, SCLs and LCLs continued to exhibit heterogeneity in circadian periods ([Fig 1A](#pbio.3000792.g001){ref-type="fig"}), suggesting that stochastic (nonheritable) variation also contributes to period heterogeneity. We estimated the contribution of heritable and nonheritable components by variance partitioning. We found that although stochastic variation contributes to both short and long periods, short circadian period is more heritable compared to long period, which is largely stochastically driven, in agreement with a recent report on immortalized mouse ear fibroblasts \[[@pbio.3000792.ref049]\]. These findings strongly suggest both heritable and stochastic components govern circadian period heterogeneity.

U-2 OS cells used in our study are a cancer-derived osteosarcoma cell line known to have high mutation propensities \[[@pbio.3000792.ref043],[@pbio.3000792.ref044]\]. Therefore, we asked whether the heritability of observed period differences between short- and long-period cells are due to genetic polymorphisms and therefore specific to U-2 OS (or other cancer) cells or whether period heterogeneity is ubiquitous and can be extrapolated to other species as well. To address these questions, we sequenced exomes of short- and long-period clones along with the founding culture, and our analysis of SNPs and CNVs revealed that these random polymorphisms are unlikely causing the observed period differences between the clones ([Fig 2B](#pbio.3000792.g002){ref-type="fig"}). In addition, we imposed a similar selection protocol using mouse NIH 3T3 cells, an immortalized murine fibroblast cell line with a much lower number of spontaneous mutations \[[@pbio.3000792.ref045]\], and also found a substantial period divergence of the clones after selection ([S4 Fig](#pbio.3000792.s004){ref-type="supplementary-material"}). Taken together, our results suggest that period heterogeneity is (1) driven by both heritable and nonheritable components, (2) unlikely to be due to genetic polymorphisms, and (3) a ubiquitous phenomenon. This raises an interesting question: why would natural selection favor the evolution of heritable mechanisms to drive period heterogeneity over entirely stochastically driven heterogeneity? We hypothesize that, although period heterogeneity can be functionally beneficial \[[@pbio.3000792.ref010]--[@pbio.3000792.ref018]\], very large heterogeneity can negatively influence clock functionality as well \[[@pbio.3000792.ref012],[@pbio.3000792.ref013],[@pbio.3000792.ref016]\]. Entirely stochastically driven heterogeneity can potentially lead to very large variation in intercellular/oscillator period, which can be detrimental, whereas heritable mechanisms may impose phenotypic constraints \[[@pbio.3000792.ref050]\], within which period heterogeneity can be maintained and thus favored by natural selection. Recently, it has been proposed that isolating fibroblasts from humans and assaying their circadian period might provide a reasonable estimate of the individual's behavioral period \[[@pbio.3000792.ref051]\]. As we report in this study, progeny clones of a single parental clone can differ in their periods, the average period of the progeny clones always resembles the parent clones' period ([Fig 2D](#pbio.3000792.g002){ref-type="fig"}). Therefore, assaying multiple cells from an individual and estimating their average period is very important for measuring of the individual's period.

Reports by Aschoff \[[@pbio.3000792.ref037]\] as well as Pittendrigh and Daan \[[@pbio.3000792.ref038]\] led the latter to hypothesize that circadian rhythms are most stable as the endogenous period (τ) approaches 24 h, whereas deviation of τ from 24 h leads to reduction in rhythm stability and provided an evolutionary reasoning for such a hypothesis. This observation of rhythm stability being the lowest at a particular τ has since been substantiated by studies on various species \[[@pbio.3000792.ref039],[@pbio.3000792.ref041],[@pbio.3000792.ref042]\], including the pacemaker SCN neurons \[[@pbio.3000792.ref040]\], but others have reported either weak or absence of such trends \[[@pbio.3000792.ref052],[@pbio.3000792.ref053]\]. To assess whether such correlation is observed mostly at the level of organisms and central pacemaker neurons or is a general property even for peripheral oscillator cells, we measured the intercycle variation in period across our clonal populations. We observed that the rhythm stability decreases (SD of intercycle period increases) with increasing clone period ([Fig 2A](#pbio.3000792.g002){ref-type="fig"}). Moreover, clones with longer periods exhibited a higher interclonal variation in rhythm stability compared to short-period clones, thereby suggesting that longer-period clones have a higher propensity of exhibiting unstable rhythms ([Fig 2A](#pbio.3000792.g002){ref-type="fig"}). Long-period mutant in *Neurospora crassa* exhibit higher amplitude and are robust compared to short-period mutants who have lower amplitudes \[[@pbio.3000792.ref054]\]. Similarly, long-period mutants of Syrian hamsters also exhibit higher amplitude whereas short-period mutants have lower amplitude and exhibit reduced rhythm stability \[[@pbio.3000792.ref052]\]. Therefore, it is conceivable that observed reduction of rhythm stability in our long-period clones may not be causally associated with circadian period but may be a consequence of reduced rhythm amplitude ([Fig 2C](#pbio.3000792.g002){ref-type="fig"}) and increased stochastic noise. Our results highlight that rhythm stability is correlated with circadian period, but it is not in agreement with previous studies that have reported increased rhythm stability at a particular τ. It is possible that the previously reported correlations are restricted to the central clock (at least in higher organisms with central and peripheral clock architecture), since the stability of behavioral rhythm is more likely to be the direct substrate for natural selection \[[@pbio.3000792.ref038]\].

Over the course of our experiments, we observed that long-period clones often exhibited higher average bioluminescence compared to the short-period clones ([Fig 2C](#pbio.3000792.g002){ref-type="fig"}; [S2A Fig](#pbio.3000792.s002){ref-type="supplementary-material"}) and further analysis revealed that parent average bioluminescence was a good predictor of progeny bioluminescence, but this was not the case for either relative amplitude or the damping rate ([Fig 2D](#pbio.3000792.g002){ref-type="fig"}, [S6A and S6B Fig](#pbio.3000792.s006){ref-type="supplementary-material"}). We reasoned that average bioluminescence could serve as a proxy measure for *BMAL1* expression and hypothesized that variation in gene expression of one or more clock and clock-associated genes might underlie period heterogeneity. To further explore this, we measured average expression of 20 circadian clock and clock-associated genes ([S4 Table](#pbio.3000792.s016){ref-type="supplementary-material"}) across all 25 clones in our panel. By employing PCA, we identified five candidate genes (*ARNTL2*, *BHLHE40*, *DBP*, *NR1D2*, and *PER2*) that grouped clones into three distinct clusters---short, intermediate, and long periods ([Fig 3A--3D](#pbio.3000792.g003){ref-type="fig"}). Furthermore, we observed that knockdown of three of the shortlisted candidates---*NR1D2*, *BHLHE40*, and *ARNTL2*---had the significantly changed periods in short- and long-period clones whereas knockdown of other genes, including those from PC1 ([Fig 3E](#pbio.3000792.g003){ref-type="fig"}), had little or no effect on period ([Fig 4A--4C](#pbio.3000792.g004){ref-type="fig"}). It is noticeable that individual knockdown of the genes resulted in small-magnitude period changes that cannot entirely account for period differences between the short- and long-period clones ([Fig 4A](#pbio.3000792.g004){ref-type="fig"}), suggesting that that period heterogeneity is likely a multigene trait involving a consortium of multiple medium-effect genes. Notably, all three above-mentioned genes are transcription factors that are either regulated by and/or act on E-boxes \[[@pbio.3000792.ref055]--[@pbio.3000792.ref061]\], suggesting that modulation of clock period is complex and governed by interaction between the interconnected molecular clock loops coupled by E-box-associated transcription factors \[[@pbio.3000792.ref062],[@pbio.3000792.ref063]\].

Intriguingly, in contrast to the above-discussed genes, we find another category among the assayed genes that exhibit an inverted-U-shaped relationship with period ([Fig 3E](#pbio.3000792.g003){ref-type="fig"}, [S10B Fig](#pbio.3000792.s010){ref-type="supplementary-material"}). The expression of these genes is high in clones with intermediate periods (23.8--26.9 h) and is drastically reduced in clones with periods deviating from the intermediate range. Furthermore, our knockdown studies also confirm that expression patterns of these genes are not causal to but likely a response/consequence to period variation ([Fig 4B and 4C](#pbio.3000792.g004){ref-type="fig"}). Such inverted-U-shaped responses (hormesis) is observed in various biological systems and is regarded as a regulatory/homeostatic mechanism to prevent very large deviations of cellular/organismal phenotypes from their optimal range \[[@pbio.3000792.ref064]--[@pbio.3000792.ref066]\]. As discussed earlier, since a higher degree of period heterogeneity can be detrimental to the circadian clock network, we hypothesize that although there are mechanisms within the clock circuitry that promote period heterogeneity, the network might also harbor hormesis-based mechanisms, which impose constraints on the range of period that the circadian clock can exhibit \[[@pbio.3000792.ref064]--[@pbio.3000792.ref066]\]. Such mechanisms may also explain why we observe a saturation of period divergence after assay generation 2 ([Fig 1C](#pbio.3000792.g001){ref-type="fig"}).

Although evidence thus far strongly suggested that period heterogeneity is driven by differences in clock-gene expressions, and having ruled out the possibility of genetic polymorphisms, we asked, What is the source of these expression differences? Epigenetic variation--driven gene expression differences often underlie phenotypic heterogeneity in many life forms, including clonal populations \[[@pbio.3000792.ref015],[@pbio.3000792.ref022],[@pbio.3000792.ref067]--[@pbio.3000792.ref070]\]. Therefore, we hypothesized that differential epigenetic regulation of gene expression may underlie period heterogeneity. To test this, we studied the effect of a HDAC inhibitor SAHA treatment on the circadian period across our clones. Interestingly, we find that treatment with SAHA significantly shortens the period in long-period clones with little or no effect on the short and intermediate clones ([Fig 4D](#pbio.3000792.g004){ref-type="fig"}). Although the magnitude of period change upon SAHA treatment is relatively small, the differential effects of SAHA on short- and long-period clones are intriguing and suggest that mechanisms underlying short and long circadian periods might be entirely different and not mechanistic opposites of each other. Furthermore, the small magnitude effect of SAHA may be also due to (1) genome-wide effects of SAHA up-regulating other genes also that in turn negatively influence the change in period, thus resulting in overall small magnitude effect on period change, and/or (2) SAHA being a broad-spectrum HDAC inhibitor that promotes up-regulation of genes by acetylation, whereas other epigenetic mechanisms that might also regulate gene expression in our clones are not targeted by this treatment. Therefore, we also assessed methylation of CpG islands proximal to transcription start sites of the three genes *ARNTL2*, *NR1D2*, and *BHLHE40*, which had maximal effect on period upon knockdown ([Fig 4A](#pbio.3000792.g004){ref-type="fig"}). We observed that CpG islands upstream of BHLHE40 were significantly more methylated in short-period clones compared to long-period clones, which correlates with the reduced BHLHE40 expression in short-period clones ([Fig 3D](#pbio.3000792.g003){ref-type="fig"}). Since BHLHE40 acts as inhibitor of E-box-mediated transcription \[[@pbio.3000792.ref071]\], it is possible that the expression levels of the other PC2 genes (*ARNTL2*, *PER2*, *NR1D2*, *DBP*) are directly regulated by BHLHE40. Together, these results suggest that different epigenetic mechanisms regulate gene expression differences and contribute to heritable components of period heterogeneity.

Results from studies over the past decade suggest that cell cycle and circadian clock may be coupled, with the consensus that cells that divide faster have shorter circadian periods, whereas the long-circadian-period cells divide slower \[[@pbio.3000792.ref005],[@pbio.3000792.ref072]--[@pbio.3000792.ref074]\]. If such coupling also exists in U-2 OS cells, then it is likely that selection for short- and long-period clones can also lead to correlated selection for higher and lower proliferation rates, respectively. To further explore this, we assayed proliferation rates of six clones (three representative short- and long-period clones) from our study by plating them at two different densities (1,000 cells/well and 5,000 cells/well) and measuring proliferation rate across 7 consecutive days using colorimetric assay. We did not find any difference in proliferation between short- and long-period clones when plated at 1,000 cells/well; however, when plated at 5,000 cells/well, we observe a trend toward long-period clones proliferating faster than short-period clones---directly opposite to previous reports ([S11 Fig](#pbio.3000792.s011){ref-type="supplementary-material"}). Although we do not have an explanation for these counterintuitive results, we speculate that (1) the proliferation differences between short- and long-period clones is not associated with period differences and that circadian clock--cell cycle coupling may be absent in cancer cell lines such as U-2 OS cells as also reported for Lewis lung carcinoma cells \[[@pbio.3000792.ref075]\] and immortalized rat fibroblasts \[[@pbio.3000792.ref076]\]. (2) Alternatively, the negative correlations between circadian period length and cell division rate observed in fibroblasts may be density dependent in U-2 OS or other cancer cells and may require further studies using different cell lines to validate this. The latter would provide an interesting avenue for future studies to explore whether period heterogeneity stems from mechanisms underlying heterogeneity in proliferation rates, which is also governed by both stochastic noise and epigenetic variation \[[@pbio.3000792.ref077]\], thus sharing common heritable basis.

In conclusion, we report that both heritable and stochastic components govern clonal heterogeneity of circadian periods and epigenetically regulated differential expression of E-box-associated transcription factors might govern period heterogeneity. Furthermore, conserved entrainment properties even in our single-cell clones underscore laboratory selection as a useful strategy to generate clonal panel exhibiting a range of circadian phenotypes that can aid interesting chronobiology studies.

Methods {#sec009}
=======

Cell culture and selection protocol {#sec010}
-----------------------------------

Cells used in this study included U-2 OS (human, ATCC \# HTB-96) and NIH 3T3 (mouse, ATCC \# CRL-1658) cells, which stably expressed firefly luciferase from a 0.9-kb *BMAL1* promoter \[[@pbio.3000792.ref032]\]. All cells were cultured and maintained in DMEM containing 10% fetal bovine serum and antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin).

For selection of clones with different circadian periods, U-2 OS cells from "founding culture" expressing a circadian period of 24.6 ± 0.16 h (mean ± SD) were plated as single-cell clones in 96-well "parent plates" and grown to confluency. On reaching confluency, a replicate "assay plate" was established from every parent plate by splitting cells. Bioluminescence rhythms of clones in assay plates were recorded (see below for recording protocol) and those exhibiting short or long periods (tails of the period distribution) were selected. We observed that in some clones, the period of bioluminescence rhythms was not reproducible when measured again; therefore, every clone was recorded two to three times and only those that consistently exhibited shot/long periods were selected. Following the selection of clones, corresponding clones from the parent plate were again single-cell cloned in 96-well plates by serial dilution (later confirmed visually through microscope by checking every plated well), and the procedure was repeated for four assay generations by selecting short- and long-period clones every generation. See [S1 Fig](#pbio.3000792.s001){ref-type="supplementary-material"} for a pictorial description of the selection protocol.

Bioluminescence recording and analysis {#sec011}
--------------------------------------

Cells were plated in white 96-well plate at a density of 20 × 10^3^ cells/well, and after 72 hours, cells were synchronized with dexamethasone (1 μM) for 30 minutes, washed twice with PBS, and cultured in Phenol-Red-free DMEM containing 10% fetal bovine serum, antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin), and 250 μM D-luciferin (BioThema, Darmstadt, Germany). Bioluminescence was recorded at 37°C in a 96-well plate luminescence counter (TopCount, PerkinElmer, Rodgau, Germany) for up to 7 days. The same selection protocol was implemented on NIH 3T3 cells as well. Bioluminescence data were analyzed by using ChronoStar software \[[@pbio.3000792.ref078]\]. In brief, the raw bioluminescence traces were detrended using a 24-h sliding window and the detrended data are used to fit a damped oscillator equation of the form y = A \* (exp\^ (−Ƴ\*t)) \*Cos (2πf\*t + φ) + error; where A = amplitude, Ƴ = damping coefficient, t = time, f = frequency, φ = phase. The best-fit values are used to extract period, decay constant (damping), relative amplitude, and mean bioluminescence intensity (MESOR) of the oscillation.

Estimation of broad-sense heritability {#sec012}
--------------------------------------

Both heritable variation (V~H~) and nonheritable stochastic/environmental variation (V~NH~) are known to contribute to phenotypic variation (V~P~ = V~H~ + V~NH~) observed in populations. We estimated broad-sense heritability (*H*^*2*^) using one-way ANOVA (outlined in [S2C Fig](#pbio.3000792.s002){ref-type="supplementary-material"}; \[[@pbio.3000792.ref034]\]). We chose a group of parental clones that vary in circadian period and assayed the circadian periods on *n* subclones from each of the parental clone and used one-way ANOVA to partition the between-clone and within-clone variance. Variation between clones can stem from both heritable and nonheritable components and is obtained by mean squares between term (MS~b~), where MS~b~ = V~NH~ + *n*V~H~ with *n* being the number of assayed subclones for each parental clone ([S2C Fig](#pbio.3000792.s002){ref-type="supplementary-material"}). However, variation within clones is expected to be largely due to nonheritable factors, since the subclones of a parental clone are genetically identical and are given by mean squares within term (MS~w~), where MS~w~ = V~NH~. Provided that the same number of subclones (*n*) is assayed for all parental clones, heritable genetic variance V~G~ can be calculated as (MS~b~−MS~w~)/*n* and nonheritable variance V~NH~ = MS~w~ ([S2C Fig](#pbio.3000792.s002){ref-type="supplementary-material"}; \[[@pbio.3000792.ref034]\]). Thus, broad-sense heritability (*H*^*2*^ = V~H~/V~P~) was estimated to be *H*^*2*^ = V~H~/(V~H~ + V~NH~).

Intercycle period stability analysis {#sec013}
------------------------------------

Detrended bioluminescence traces were analyzed in R using peakPick package \[[@pbio.3000792.ref079]\] to identify peaks in the data. The duration between two consecutive peaks represents the period of that cycle and the SD of periods across multiple consecutive cycles was used as a measure of intercycle period stability. Since short-period rhythms have more cycles than long-period rhythms in a given time duration, we restricted the number of cycles considered for analysis to three to four cycles for all the time series data analyzed.

Whole-exome sequencing and analysis {#sec014}
-----------------------------------

Genomic DNA was isolated using Qiagen Blood & Cell Culture DNA Mini Kit (Cat. \# 13323). DNA quality was monitored on 1% agarose gels and concentration was measured using Qubit DNA Assay Kit in Qubit 2.0 Flurometer (Life Technologies, Carlsbad, CA, USA). Exomes were captured using and Agilent SureSelect Human All Exon kit V6 (Agilent Technologies, Santa Clara, CA, USA) following manufacturer\'s recommendations, and enriched libraries were sequenced at 50X on Illumina Novaseq (2 × 150 bp) platform by Novogene. After quality-filtering raw reads, clean paired-end reads were mapped to human reference genome (hg38) using Burrows-Wheeler Aligner \[[@pbio.3000792.ref080]\]; the resulting BAM files were sorted using SAM tools \[[@pbio.3000792.ref081]\] and Picard was used to mark duplicate reads \[[@pbio.3000792.ref082]\]. GATK \[[@pbio.3000792.ref083]\] was used for calling SNPs and small insertions and deletions (InDels). CONTRA \[[@pbio.3000792.ref084]\] was used for CNV detection. Variant annotation and effect prediction were performed using ANNOVAR \[[@pbio.3000792.ref085]\] and VEP \[[@pbio.3000792.ref086]\].

RNA isolation and NanoString-based gene expression analysis {#sec015}
-----------------------------------------------------------

Cells were plated at a density of approximately 20 × 10^3^ cells/well in 24-well plate with DMEM containing 10% fetal bovine serum and antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin) and were left undisturbed without medium replacement for 144.5 h. When handled this way, the cell population was essentially arrhythmic by day 6, with relative amplitudes reducing by approximately 95%, comparing day 1 amplitude (0.44 ± 0.09; mean ± SD) with day 6 (0.02 ± 0.01; mean ± SD)---a residual amplitude too low to be biologically significant ([S7A and S7B Fig](#pbio.3000792.s007){ref-type="supplementary-material"}). In addition, we measured *DBP* (a circadian clock gene with high-amplitude expression) expression on two different instances in representative SCL and LCL clones on day 6 by sampling cells over 28 h between 144.5 ± 14 h. We did not find *DBP* expression to be rhythmic in either of the clones (MetaCycle *p* \> 0.5; [S7C and S7D Fig](#pbio.3000792.s007){ref-type="supplementary-material"}).

At 144.5 h post cell plating, the culture medium was aspirated, and 100 μl/well iScript RT-qPCR Sample Preparation Reagent (Bio-Rad) was added on top of the cell layer and incubated at 37°C for 5 min. A sample of 3 μl was withdrawn without disturbing the cell layer and used for further downstream analysis.

A previous study of ours combined whole-genome transcriptomics with machine learning and identified genes that can serve as reliable circadian markers \[[@pbio.3000792.ref087]\]. Based on this, we designed a 24-plex NanoString probe panel comprising 20 circadian clock and clock-associated genes along with four housekeeping genes ([S1 Table](#pbio.3000792.s013){ref-type="supplementary-material"}). The custom-designed probes included a 3′-end biotinylated capture probe and a 5′-fluorescence-barcoded reporter probe for each gene target. Hybridization of probes and gene expression--count reading was according to the manufacturer's instructions. Raw expression data were acquired by a NanoString nCounter Digital Analyzer (NanoString Technologies), QC processed, and analyzed by nSolver. Of the 24 genes in the panel, we discarded data from one gene (*CIART*) because it failed to pass QC analysis. Data normalization involved three steps: (1) normalization by the arithmetic mean of the positive spike-in controls, (2) subtraction of the mean of all negative controls, and (3) normalization by the geometric mean of the four housekeeping genes.

For all other experiments not involving NanoString platform, total RNA was isolated with AMBION PureLink RNA Mini kit (Thermo Fisher) including an on-column DNase digest according to manufacturer's instructions. The isolated RNA was then reverse transcribed using M-MLV Reverse Transcriptase (Life Technologies), and gene expression was measured by qPCR in a CFX96 thermal cycler (Bio-Rad, Munich, Germany) using gene-specific QuantiTect primers (Qiagen).

PCA and clustering {#sec016}
------------------

Log~2~-transformed gene expression data were first subjected to Bartlett's Test of Sphericity to validate its adequacy for PCA, after which correlation-based PCA was implemented in R \[[@pbio.3000792.ref088]\] using factoextra and FactoMineR packages \[[@pbio.3000792.ref089]\]. Broken Stick model \[[@pbio.3000792.ref047]\] was used to determine the number of retainable PCs. Determining the optimal cluster number is often a complication in unsupervised exploratory data analysis. Unlike many studies in biology that employ PCA to identify genes based on expression differences between known cell types (which can be used to estimate the optimal number of clusters), our study employs a panel of clones with a continuous distribution of phenotypes (period) and thus cannot be categorized trivially. Hence, we adopted two schemes for optimal cluster number determination. (1) For agglomerative hierarchical clustering, we assessed the agglomeration schedule to identify the possible number of clusters \[[@pbio.3000792.ref090]\]. (2) In addition, we performed k-means clustering for different values of cluster (k = 1--10) and used five different indexes---\"silhouette method" \[[@pbio.3000792.ref091]\], "elbow method" \[[@pbio.3000792.ref092]\], "gap statistic" \[[@pbio.3000792.ref093]\], "Calinski-Harabasz criterion value (variance-ratio method)" \[[@pbio.3000792.ref094]\], and Bayesian information criterion (BIC; \[[@pbio.3000792.ref095]\])---to assess the optimal cluster number. We selected the optimal cluster number based on agreement between (1) and (2). Heatmapper \[[@pbio.3000792.ref096]\] and "dendextend" \[[@pbio.3000792.ref097]\] were used for hierarchical clustering analysis based on "euclidean-distance" and "complete-linkage" measures \[[@pbio.3000792.ref098]\]. "Nbclust" \[[@pbio.3000792.ref099]\] and "mclust" \[[@pbio.3000792.ref100]\] were used for k-means-based clustering analysis, and for all others, statistical analysis and graphing was performed using R and Prism version 8.00 for Windows (GraphPad Software, La Jolla, CA, USA, [www.graphpad.com](http://www.graphpad.com/)).

RNAi-mediated gene knockdown {#sec017}
----------------------------

The GIPZ microRNA-adapted shRNA constructs used for the study were purchased from Open Biosystems and packaged into lentiviral vectors in HEK293T cells in a 96-well plate format \[[@pbio.3000792.ref032]\]. Virus-containing supernatants were then filtered and U-2 OS cells were transduced with 150 μL of the filtrate containing 8 ng/μL protamine sulfate. The filtrate was replaced after at least 24 h with fresh medium containing puromycin (10 μg/mL). After 3 days, the transduced cells were synchronized and bioluminescence was recorded as described above.

Cell proliferation assay and SAHA treatment {#sec018}
-------------------------------------------

To measure cell proliferation, cells were plated in 96-well plates at two different densities (1,000 and 5,000 cells/well) and four replicates each. Starting 24 h after plating, cell proliferation was measured for 7 consecutive days by colorimetric assay with Vybrant MTT Cell Proliferation Assay Kit (Thermo Fischer Scientific, catalog \#V13154). To account for errors in cell counting and plating, absorbance on day 1 was set to 1 and absorbance on consecutive days was calculated relative to that on day 1.

For experiments involving SAHA treatment, 10^3^ cells/well were plated in 96-well plates on day 0. After 24 h, culture medium was replaced with media containing 1.6 μM SAHA or DMSO vehicle control. Drug-containing medium was replaced every day for 3 consecutive days, after which cells were rinsed thrice with PBS, and fresh culture medium without drug was added on day 4. Since wells are 50% confluent on day 4 (see IC~50~ estimation below), to avoid artefacts density on circadian period, cells were left untreated for 48 h and bioluminescence rhythms were recorded from day 6.

The above-described protocol was followed for estimating IC~50~ value as well. Cells were treated with varying concentrations (0--100 μM) of SAHA from day 1, and cell proliferation was assayed on day 4 using the Vybrant MTT Cell Proliferation Assay Kit (Thermo Fischer Scientific, catalog \#V13154) as per manufacturer's protocol. IC~50~ was calculated from the resulting dose-response curve using Prism version 8.00 for Windows (GraphPad Software, La Jolla, CA, USA, [www.graphpad.com](http://www.graphpad.com/); [S12 Fig](#pbio.3000792.s012){ref-type="supplementary-material"}).

Methylation analysis {#sec019}
--------------------

Methylation was assessed by methylation-sensitive restriction enzyme (MSRE)-based qPCR using OneStep qMethyl-PCR Kit (Zymo Research). CpG islands spanning transcription start sites of respective genes were identified and sequences were extracted using Genome Browser ([http://genome.ucsc.edu/](https://genome.ucsc.edu/index.html)). Primers were designed using NCBI Primer-BLAST to contain at least two MSRE sites as per manufacturer's guidelines. Two sets of primers targeting different regions of the CpG islands were tested for every gene, and one set per gene ([S5 Table](#pbio.3000792.s017){ref-type="supplementary-material"}) was considered based on amplification efficiency and measured percent methylation for the given region. Genomic DNA was isolated from confluent cells in a 6-well plate using Qiagen Blood & Cell Culture DNA Mini Kit (Cat. \# 13323) and used for qPCR with cycling conditions as suggested in manufacturer's protocol.

Supporting information {#sec020}
======================

###### Graphical depiction of the selection protocol.

The selection protocol adopted for deriving the panel of short- and long-period clones used in this study is graphically represented.

(TIF)

###### 

Click here for additional data file.

###### Both heritable and nonheritable components underlie divergence in circadian period between the short- and long-period clones.

**(A)** Raw bioluminescence traces of representative clones from founding culture (dashed line), short-period (red), and long-period (blue) clonal lines. **(B)** Regression of progeny cultures' periods on mean periods of their parental cultures' periods. Each data point is an average of three to five experiments. Blue solid line is the linear regression fit with its 95% CI (green dotted line). **(C)** Pictorial depiction of variance partitioning between and within clones to estimate heritability. If a group of parental clones (P1--P6) exhibiting different circadian periods are considered and their *n* progeny periods are assayed, the between-clone variance (MS~b~) provides an estimate of phenotypic variation due to both heritable (*V*~*H*~) and nonheritable (V~*NH*~) mechanisms, whereas the within-clone variance (MS~w~) is likely due to nonheritable/environmental variation (*V*~*NH*~). Thus, these two variance components can be used to estimate heritability (*H*^*2*^) as depicted above. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}.

(TIF)

###### 

Click here for additional data file.

###### In accordance with entrainment theory, short- and long-period clones entrain with different phases.

Entrainment profiles of a representative short- (red) and long-period (blue) clone to T24 (12 h of 37°C and 33°C each) (top panel) and T26 (13 h of 37°C and 33°C each) (bottom panel). Red and blue dots indicate peak phases on respective days, and blue-shaded boxes indicate low temperatures. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}.

(TIF)

###### 

Click here for additional data file.

###### Clonal heterogeneity in circadian period is likely a ubiquitous phenomenon.

Divergence of circadian period distributions of short-period (red) and long-period (blue) clones from a common founding culture (gray) across one assay generation for NIH 3T3 cells. Dashed black lines depict the mean of respective period distributions. The gray dashed lines extended from assay generation 1 depict mean period of the founding culture (assay generation 0) for visual assessment of the period divergence. Red arrows (short-period clone) and blue arrows (long-period clone) indicate the periods of representative clones selected for the successive assay generation. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}.

(TIF)

###### 

Click here for additional data file.

###### Clonal circadian period heterogeneity in U-2 OS cells is likely not due to polymorphisms.

mRNA expression (normalized to *GAPDH*) of **(A)** *SART3*, **(B)** *ZMAT3*, and **(C)** *GFAP* comparing three short (SCL) and long (LCL) representative clones each. SCLs and LCLs were not significantly different in their expression of the above-mentioned genes (randomized block design ANOVA, *p \>* 0.05). Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. LCL, long-period clonal line; SCL, short-period clonal line.

(TIF)

###### 

Click here for additional data file.

###### Relative amplitude and damping rate are weakly heritable.

Linear regression of mean progeny values on parental values for **(A)** relative amplitude (*R*^2^ = 0.04) and **(B)** damping rate (*R*^2^ = 0.40). Each data point is an average of three to five experiments. Green solid line is the linear regression fit with its 95% CI (green dotted line). \*\*\*\**p* \< 0.0001. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}.

(TIF)

###### 

Click here for additional data file.

###### Observed differences in gene expression across 25 clones is not a phase effect.

**(A)** Bioluminescence traces of representative clones from our clonal panel depicting the damping of rhythm over 6 days. Blue-shaded regions indicate the time windows on day 1 and day 6 when the amplitude was measured (shown in B). Red dashed line indicates the time at which RNA was isolated for gene expression quantification ([Fig 3D and 3E](#pbio.3000792.g003){ref-type="fig"}). **(B)** Relative rhythm amplitudes on day 1 and day 6 of the bioluminescence traces presented in (A). Error bars are SD across 30 clones. **(C)** mRNA expression of *DBP* (normalized to *GAPDH*) from an SCL and LCL sampled at 4-h intervals for 28 h on day 6, blue-shaded region in (A). To ensure reproducibility, SCL and LCL were sampled independently on two different experiments. MetaCycle analysis did not report a significant rhythmicity in either of the clones. Error bars are SD across three qPCR runs. **(D)** Average (across 28 h) *DBP* expression in SCLs and LCLs as measured on day 6. In agreement with [Fig 3D](#pbio.3000792.g003){ref-type="fig"}, SCLs have higher *DBP* expression compared to LCLs, thus further confirming that the gene expression measured on day 6 indicates gene expression from asynchronous clones. Error bars SD across time points for the three qPCR runs. \*\*\*\**p* \< 0.0001. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. LCL, long-period clonal line; qPCR, quantitative PCR; SCL, short-period clonal line.

(TIF)

###### 

Click here for additional data file.

###### Heritable variation in circadian clock genes likely underlies clonal heterogeneity in circadian period.

**(A)** Pearson correlation of gene expression among 19 clock and clock-associated genes assayed in our clonal panel indicates a high degree of cross-correlation between the clock genes, likely due to the interconnected molecular clock network where change in expression of one gene drives expression changes in many other genes. Because of such high correlations between the genes measured, we adopted PC analysis to identify genes contributing the most to period heterogeneity. **(B)** Variable (gene) correlation map used to visually assess how strongly a variable (gene) is correlated with a PC. In general, the lower the angle between the vector depicting the gene and the PC, the stronger the correlation of the gene with the PC. **(C-D)** Contributions of the 19 analyzed genes to PC2 and PC1 respectively. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. PC, principal component.

(TIF)

###### 

Click here for additional data file.

###### Top five genes from principal component 2 cluster clones into three groups, whereas those from principal component 1 clusters clones into two groups.

To estimate the optimal number of clusters in our dataset, we measured five different k-mean clustering indexes (average silhouette width, WSS, gap statistic, Calinski-Harabasz value, and Bayesian information criterion) for k = 1--10 clusters. **(A**-**E)** Values of the above-mentioned indexes across 10 clusters generated by the five selected genes from principal component 2. **(F-J)** The same for clusters generated by the five selected genes selected from principal component 1. The red dots indicate the optimal cluster number chosen based on the respective index measure. Details of the indexes used and their interpretation can be found in the respective references (see [Methods](#sec009){ref-type="sec"}). In brief, for all indexes except WSS, the cluster number resulting in the highest value of the index was considered likely to be the optimal cluster number. For WSS, the cluster number at which the WSS plot forms an elbow joint (the magnitude of drop in WSS values reduces thereafter) was considered as the likely optimal cluster number. When more than one optimal cluster number is observed, as in (C), (D), and (H), the decision was based on guidelines suggested by the original authors. Raw data used for analyses in this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. WSS, within sum of squares.

(TIF)

###### 

Click here for additional data file.

###### Clonal heterogeneity in circadian period is associated with altered expression of clock and clock-associated genes.

Trends of gene expression across clones exhibiting different circadian periods for the five selected genes from **(A)** PC2 and **(B)** PC1. *r* = Pearson correlation coefficient and *R*^2^ = goodness of linear regression fit (blue solid lines) to estimate the proportion of variance in clone period explained by variance in gene expression. \**p* \< 0.05; \*\**p* \< 0.001; \*\*\**p* \< 0.0001; \*\*\*\**p* \< 0.00001. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. PC, principal component.

(TIF)

###### 

Click here for additional data file.

###### Both cell density and circadian period likely influence cell proliferation.

Assessment of cell proliferation rate across 7 consecutive days in SCLs and LCLs post plating at different starting densities---1,000 cells/well **(A)** and 5,000 cells/well **(B)** in a 96-well plate. To account for variations in cell counting and plating, absorbance values are expressed relative to day 1. Error bars represent SD across three representative SCLs and LCLs used. Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. LCL, long-period clonal line; SCL, short-period clonal line.

(TIF)

###### 

Click here for additional data file.

###### Estimation of IC~50~ value for SAHA treatment.

To estimate IC~50~ value for SAHA, cells were treated with varying concentrations of the drug (0--104 μM) for 3 days (see [Methods](#sec009){ref-type="sec"}), after which cell proliferation was measured as absorbance at 570 nM using Vybrant MTT Cell Proliferation Assay Kit (Thermo Fischer Scientific, catalog \#V13154). From the resulting dose-response curve, IC~50~ was calculated using Prism version 8.00 for Windows (GraphPad Software, La Jolla, CA, USA, [www.graphpad.com](http://www.graphpad.com/)). Error bars on data points represent SD (*n =* 3). The solid dashed line is the nonlinear regression fit with its 95% CI (dotted line). Underlying data for this figure can be found in [S1 Data](#pbio.3000792.s013){ref-type="supplementary-material"}. SAHA, suberoylanilide hydroxamic acid.

(TIF)

###### 

Click here for additional data file.

###### 
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Please note that we cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers\' comments. Your revised manuscript would be sent for further evaluation by the reviewers.
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REVIEWS:

Reviewer \#1 (John O\'Neill):

This manuscript addresses a fascinating biological question, is nicely written, with the data describing the phenomenon being most convincing, and resulting from a well-conceived screen. Essentially, the authors ask what proportion of the variation in the fidelity of circadian transcriptional rhythms in cultured human cells is hereditable. They design an assay to identify and isolate several short and long period clones and then investigate the extent to which variation in clock gene expression accounts for period phenotype.

The authors note that their findings in later figures are somewhat preliminary but there is an issue with the interpretation of the data presented in figures 2 & 3 that I feel the authors really should address, and will require just a couple of simple experimental controls for circadian phase and cell division as described below:

Cell division control -- U2OS cells are transformed and do not fully contact inhibit i.e. they reach a steady state where the rate of cell death = rate of cell division. Since circadian period is affected by cell division, with the consensus being with faster dividing cell populations having a shorter periods (Nagoshi et al, Cell, 2004; O'Neill & Hastings, JBR, 2008; Feillet et al, PNAS, 2014; Bieler et al, Mol Syst Biol, 2014). Thus, a plausible interpretation of the data in figure 1 is that the screen has selected for clones with different doubling times such that SCL clones proliferate more rapidly than the parental line, LCL clones proliferate more slowly. A simple measurement of doubling time of the different clones would reveal whether this alternative hypothesis can be rejected or not, but either way this control is essential for understanding the inferences that can reasonably be made about circadian timing in the different clones. Indeed, if there is a reasonable correlation between cell proliferation and circadian period the authors can estimate what proportion of period heritability can be attributed to differences in cell division compared with the other variables they consider.

Circadian phase control -- Perhaps the authors are not aware that a media change to fresh media containing 10% serum synchronises cells just as effectively as dexamethasone, and so the clonal lines used for RNA expression analysis in Figures 2 & 3 simply cannot be assumed to be asynchronous, as implied in the methods section. From current understanding of the molecular clock mechanism, the mRNA levels of most of the genes on the nanostring chip will change over the course of each circadian cycle. It is therefore quite plausible that differences in clock gene mRNA levels detected between the different clones result from their being at different circadian phases at the time of RNA extraction, due to their inherent differences in period described in figure 1 i.e. once 5 days have passed since the media change, the inherent differences in period will ensure that these cells are at different phases to each other and therefore have different mRNA levels. To address this potential confound, the authors simply need to take each of the clonal lines used for RNA extraction, culture them using the same protocol (including media change with 10% serum), and record bioluminescence from them for 5 days so that they know with high accuracy the circadian phase of each of the clonal lines at the time of sampling. They can then repeat some of the analyses in figure 2 to address to what extent phase differences can account for the differences in gene expression observed between clones with different circadian periods.

Both of the controls above are quick to perform (\<2 weeks duration)) and will enormously strengthen the amount of confidence that can be placed in the authors conclusions i.e. they assume causality to be:

Change in clock gene expression =\> difference in period

But equally plausible are two competing hypotheses:

Shorter/longer cell cycle =\> shorter/longer circadian period =\> altered clock gene expression

&/or

Altered circadian period =\> different phases at time of sampling =\> altered gene expression detected

Whereas these alternate possibilities really need to be excluded, or at least addressed, for the rest of the results section and discussion to hold water.

Minor comments:

To aid the comprehension of the non-expert reader, it would be very helpful if the authors could present representative bioluminescence traces in a main figure, rather than requiring the reader to look into the supplementary data. This is because the differences in period of oscillation and bioluminescence level between different clonal populations are the phenomenon under investigation, and so it will be much easier to understand for a naïve reader to understand what was observed if they have an example in front of them.

For the method of analysis of bioluminescence data, the authors cite a paper that is not yet published and could not be downloaded -- when I clicked on the related manuscript link it simply downloaded the present manuscript again. Therefore, whilst I am quite sure there is no problem with their analyses, it is not the method of analysis was not something I was able to assess. I presume, for example, that the first 24h of bioluminescence data were excluded from analysis since this is affected by the transient response to DXM and cannot be assumed to be purely circadian regulated. Please can the authors report their analysis method in the methods section.

Figure 3a/b needs some quantification for knockdown efficacy so that the effect on period can be compared with the data presented in Supp Fig6.

Fig2d shows a very small effect size and is only just significant i.e. it could be a fluke. A couple of additional HDAC inhibitors showing the same differential effect on period would be more convincing.

Page 4, first line. The assumed mutation rate for human cells is not appropriate for these highly transformed cancer cells, which (almost by definition) will be defective in one or more DNA repair mechanisms. Indeed since U2-OS cells are aneuploid (Mukherji M, et al. 2006, PNAS), the authors should check whether any of the genes in PC2 or PC1 are on the same chromosome, as a change in chromosome copy number could also account for their observations - in principle at least.

\--

Reviewer \#2:

The manuscript entitled \"Heritable gene expression variability governs clonal heterogeneity in circadian period\" by Nikhil et al. is an imaginative approach to defining major determinants underlying the period of cellular circadian clocks. The authors reach conclusions that may surprise many chronobiologists, and is a worthy addition to the literature, both in terms of approach and results obtained.

Major points:

1\. The results with SAHA in Fig. 3d show such a small period difference that (even if statistically significant) are unlikely to be biologically significant/informative as to the period differences between the \"short\" and \"long\" clones. Please see Point \# 4 below.

2\. DISCUSSION: in Baggs et al. 2009, siRNA knockdown of Bmal2 had no effect on period. Do the authors have an explanation for the difference between their results (e.g., with the \"intermediate clone\") and those of Baggs et al. ?

3\. General point: in the opinion of this reviewer, the authors\' strategy to emphasize \"heritable mechanisms to drive period-heterogeneity over entirely stochastically driven heterogeneity\" is a so-called \"red herring\" (i.e., misleading or distracting). Based on what we know about circadian clocks, OF COURSE it will be heritable rather than stochastic. But for the authors to prove this point, they need to do exosome sequencing and methylome sequencing. In other words, the authors need to prove that this is a heritable effect by demonstrating either epigenetic marks and/or genetic polymorphisms (again, see Point \# 4 below).

4\. The authors\' arguments against genetic polymorphisms being responsible for the effects they observe (starting line 263) are unconvincing, especially given that the changes they observe with SAHA are small and unlikely to be biologically significant (especially for period shortenings). U2OS cells are derived from osteosarcoma and therefore like most cancer cells are probably hypermutable. The authors appear to be arguing rather than doing the obvious experiment, which is to sequence the four major contributing genes that the PC analysis identifies: NR1D2, DBP, ARNTL2, and BHLHE40 (they can do at least exome sequencing). If they find no genetic polymorphisms, then they should undertake bisulphite sequencing (methyl-Seq) to determine if their preferred \"epimutation\" interpretation is supported by experimental measurements rather than by speculation.

Minor points:

\(a\) The description of the Principal Component Analysis is not understandable to me. I\'m hoping that one of the other reviewers understands this analysis and can comment authoritatively upon it. If the other reviewers have a similar problem to mine, then the authors need to explain better what is really being compared here.

\(b\) Line 49: there is no Leise et al. 2016 in the reference list. Do the authors mean Leise et al. 2012 ?

\(c\) In some of the figures (e.g., lines in Fig. S2, dots in Fig. 2d, and even the histograms in Fig. 3a/b), the difference between blue and green is hard to see. Please change some of the line forms (i.e., dashed vs. solid) or use black instead of blue or green.

\(d\) Fig. S3c: correct typo in abscissal label \"damping.\"

\(e\) Fig. 2b: explain the Pearson correlation coefficient here. Explanation of this panel is inadequate in the legend and non-existent in the Methods. What is being correlated here?

\(f\) DISCUSSION: please discuss whether the authors believe this period heterogeneity to be generalizable in vivo, or is only observable with cancer cells. If the authors believe this to be generalizable to normal cells in vivo, please discuss whether the authors expect there to be a mosaic of circadian periods in the body? If that is true, then perhaps the approach used by other labs of isolating fibroblasts from the body and comparing the fibroblast periods in vitro with chronotype (as has been reported by other groups) is not a valid approach ?

\--

Reviewer \#3:

This is an outstanding paper describing a clever, hypothesis-directed experiment The results are satisfying to see and they will launch a multitude of experiments that will on one hand elaborate cellular principles of the circadian clock and on the other hand molecular mechanisms. There are many gems in this paper that remain undeveloped. Given that it is a short report, perhaps this is intentional. One important but obscure principle that is elaborated is that short periods are not the mechanistic opposite of long ones. By showing the differential effect of SAHA, this concept is clear and should help us to understand how this property is regulated and what it is for.

Here are comments which are all minor:

1\. As it reads:

11\. A ubiquitous feature of circadian clocks across life forms is its organization as a network of

12\. 13 coupled cellular oscillators.

The first sentence of the abstract is not correct. How do we know that liver cells are coupled versus just oscillating with an accurately similar period? What about cyanobacteria? Is there evidence that they couple?

2\. It is important to be completely thoroughly clear on what is being described. The authors confuse the reader when they start the results section with:

76\. Is the variation in period among individual circadian oscillator cells just due to intrinsic and/or

77\. 79 extrinsic stochastic noise?

Stochastic was defined but not intrinsic and extrincis and these distinctions are not used much after this point. Further, stochastic is not used much in the discussion. Maybe is it not necessary?

3\. This:

76\. As expected, we observed a distribution of circadian periods

is a novel finding for U2OS. There is a lot of information in here. Is the gentle curve of expression of LUC in these cells attributable to the period distribution or to gentle kinetics of expression? We have seen this distribution of periods in SCN neurons and which other cells?

4\. The use of significance as a word:

76\. the periods of short and long period clonal lines (SCL and LCL)

77\. 92 significantly diverged from each other

Indicate the statistical significance here. The following sentence indicates that the divergence is not significant after generation 2. The use of significance must be cleaned up. Why give the values in one place and not the other. Also I am confused by the statistics used here. Anova picks up differences and here the p is very low. Why is this used to justify lack of divergence?

5\. How was the number of cells controlled for?

97\. We observed a positive correlation of bioluminescence intensity

6\. It might be good to check in with Baggs et al who did extensive siRNA studies:

97\. correlation of relative amplitude with period was negative

7\. The wording here is vague:

97\. We reasoned that mean

98\. 114 bioluminescence intensity can, in-principle serve as a proxy for the average expression level

Some people read expression "how much is there at a given time" others read it "how much is produced at a given moment". This should be clarified because here it is important to refer to the first definition.

8\. Here, I believe that the cells probably do not respond to the selection protocol.

202\. thus resulting in a directional response (divergence of short and long

203\. 204 period clones from the founding culture) to our selection protocol

9\. It would be elegant if the authors could refer to old observations on Neurospora mutants (the long period frq7 is more robust, higher amplitude than wt; the short frqs is lower. In flies, the short period pers is more robust than wr, the long mutant perl is less.

202\. long-period clones often exhibited higher

203\. 218 bioluminescence intensity

10\. Along the same lines, ANRT2 expression is dependent on BMAL1/ARNT1. It would be nice to discuss this since the ARNL2 levels are so important for the conclusion here.

11\. For bioluminescence intensity: how do we know for sure that after 5 d in cluture, the cells would be non-synchronised?

12\. I don't completely agree with this proposition. When one looks at the multiple loops, mutations in e.g. the revERBs for instance look like a more devastating loss to the clock than Per2 for instance. I think it is only historical that PER CRY is core and the others are auxiliary. Per Cry was described first.

224\. This reinforces the idea that while persistence of circadian oscillation requires

225\. 239 a functional core clock loop involving negative feedback by the PER-CRY family, modulation of

226\. 240 clock period might be governed by interaction between multiple loops coupled by E-box

227\. 241 associated transcription factors

13\. Grammar: are observed

228\. responses (Hormesis) is observed

14\. Below, is an interesting proposition. The authors might report the percent rhythmic clones in each of the cloning steps. One might expect more non-rhythmic clones or not if the below proposal is correct.

245\. the network might

246\. 259 also harbour hormesis-based mechanisms which impose constraints on the range of period that

247\. 260 the circadian clock can exhibit

15\. Important here to specifiy if it is an order of or orders of?

267\. are observed to be order of

268\. 282 magnitude higher than DNA mutation rates

16\. Please report the method of cloning. FACS? LDA?

311\. were plated as

312\. 318 single-cell clones in 96-well 'parent plates' and grown to confluency.

17\. There is an elephant in the room in that the relationship of phase and period is never discussed in the results section. Might add a nice dimension.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

10.1371/journal.pbio.3000792.r003
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1 Jun 2020

Dear Achim,

Thank you for submitting your revised Short Report entitled \"Heritable gene expression variability and stochasticity govern clonal heterogeneity in circadian period\" for publication in PLOS Biology. I have now obtained advice from the Academic Editor who has evaluated your revision. We\'re delighted to let you know that we\'re now editorially satisfied with your manuscript. The Academic Editor was very pleased with the exome sequencing and the experiments on entrainment in the different clones with different periods, and we appreciate the addition of another cell line, which is important, and the data showing that it is not a phase but period effect. My only remaining questions are the following:

\- Regarding the figure and table in the response to reviewers file - if this is not already present, and discussed, in some way in the main manuscript, or supplement, please consider adding it as it may help readers who have similar questions to the reviewers.

\- Data - your Data Availability Statement currently says \"Data are from our study whose authors may be contacted at <achim.kramer@charite.de>\" - this does not comply with the PLOS Data Policy, which can be found here: <https://journals.plos.org/plosbiology/s/data-availability>

Please see below for more details about the Data Policy and related requests.

Before we can formally accept your paper and consider it \"in press\", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can\'t proceed until these requirements are met, your swift response will help prevent delays to publication. Please also make sure to address the data and other policy-related requests noted at the end of this email. IMPORTANT: Please also make sure to address the data and other policy-related requests noted at the end of this email.

\*Copyediting\*

Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

<https://journals.plos.org/plosbiology/s/supporting-information>

\*Published Peer Review History\*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

<https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/>

\*Early Version\*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

\*Protocols deposition\*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods>

\*Submitting Your Revision\*

To submit your revision, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' to find your submission record. Your revised submission must include a cover letter, a Response to Reviewers file that provides a detailed response to the reviewers\' comments (if applicable), and a track-changes file indicating any changes that you have made to the manuscript.

Please do not hesitate to contact me should you have any questions.

Sincerely,

Hashi Wijayatilake, PhD,

Managing Editor

PLOS Biology

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: <http://journals.plos.org/plosbiology/s/data-availability>. For more information, please also see this editorial: <http://dx.doi.org/10.1371/journal.pbio.1001797>

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1\) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as \'Supporting Information\' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2\) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Figs. 1ABC, 2A-D, 3A-E, 4A-E, S2AB, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

BLOT AND GEL REPORTING REQUIREMENTS:

For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article\'s figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: <https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements>

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

10.1371/journal.pbio.3000792.r005
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13 Jul 2020

Dear Dr Kramer,

On behalf of my colleagues and the Academic Editor, Samer Hattar, I am pleased to inform you that we will be delighted to publish your Research Article in PLOS Biology.

The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you\'ll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication.

Early Version

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <biologypress@plos.org>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <http://www.plos.org/about/media-inquiries/embargo-policy/>.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.

Kind regards,

Alice Musson

Publishing Editor,

PLOS Biology

on behalf of

Ines Alvarez-Garcia,

Senior Editor

PLOS Biology
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